SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-003042
Filing Date
2014-08-01
Accepted
2014-08-01 07:30:35
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q thld-10q_20140630.htm 10-Q 1443405
2 EX-5.1 thld-ex5_20140630470.htm EX-5 13536
3 EX-10.5 thld-ex10_20140630471.htm EX-10 235014
4 EX-31.1 thld-ex31_201406306.htm EX-31 14018
5 EX-31.2 thld-ex31_201406307.htm EX-31 14270
6 EX-32.1 thld-ex32_201406308.htm EX-32 5762
7 EX-32.2 thld-ex32_201406309.htm EX-32 6075
  Complete submission text file 0001564590-14-003042.txt   8739616

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT thld-20140630.xml EX-101.INS 1659182
9 XBRL TAXONOMY EXTENSION SCHEMA thld-20140630.xsd EX-101.SCH 30639
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thld-20140630_cal.xml EX-101.CAL 37779
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thld-20140630_def.xml EX-101.DEF 222944
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE thld-20140630_lab.xml EX-101.LAB 268049
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thld-20140630_pre.xml EX-101.PRE 258657
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32979 | Film No.: 141008032
SIC: 2834 Pharmaceutical Preparations